• industry news
  • Orthocell claims top spot at national competition Pitch@Palace

Orthocell claims top spot at national competition Pitch@Palace

10th October 2019

Medilink WM member Orthocell, the Australian regenerative medicine company, has been declared a winner in the national final of the coveted Pitch@Palace competition – a global movement started by the British royal family, which aims to amplify the work of entrepreneurs and deepen their global impact.

Orthocell CEO, Paul Anderson, participated in a series of workshops and pitches last week, which culminated in a final three-minute pitch to an audience of more than 200 people at Government House in Perth on Friday tonight. Dignitaries included Duke of York, Prince Andrew, West Australian Governor, Mr Kim Beazley, and former Minister for Foreign Affairs, Julie Bishop, and a range of corporate influencers too.

He shared, with great integrity, insight into the progress of Orthocell’s researchers and partnering surgeons in proving the merits of the Company’s CelGro® collagen medical device for repairing complex nerve damage. The kind of injuries that can leave people completely paralysed or with severely compromised quality of life.

“The peripheral nervous system connects nerves from the central nervous system, the brain and spinal cord, to the rest of the body. Nerve damage can be debilitating and can cause severe pain, impaired use of a limb or complete paralysis,” he said.

“Repairing severed nerves requires extremely delicate surgery. The typical methodology of using sutures to rejoin the nerves, puts strain on the site of injury and can be ineffective or unpredictable in restoring function to the affected limbs.

“Our CelGro® device aims to address these challenges by providing better and faster return of function to the affected limbs. We shared this medical innovation with the audience on Friday night, and I am delighted we are now through to the global final,” said Mr Anderson.

Mr Anderson shared stories from patients who have already experienced a significant improvement in their mobility, following treatment with the device, and the Company’s goal to reach and improve the lives of more than 1-million people living with severe nerve damage every year.

“We expect to gain tremendous exposure via the Pitch@Palace event and the extended alumni community.We are privileged to be a finalist in the global innovation event, showcasing world class innovation at the St James Palace, London in December,” said Mr Anderson.

  • Share:

Sign Up to receive our newsletter

© Medilink WM. All rights reserved.

Created by Gritt and Co